home / stock / xrtx / xrtx quote
Last: | $1.7619 |
---|---|
Change Percent: | 1.7% |
Open: | $1.8382 |
Close: | $1.7619 |
High: | $1.8382 |
Low: | $1.7619 |
Volume: | 2,984 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.7619 | $1.8382 | $1.7619 | $1.8382 | $1.7619 | 2,984 | 07-02-2024 |
$1.87 | $1.9 | $1.87 | $1.9 | $1.83 | 3,846 | 07-01-2024 |
$1.9 | $1.9 | $1.9 | $1.97 | $1.8393 | 4,120 | 06-28-2024 |
$1.9259 | $1.92 | $1.9259 | $2.13 | $1.8101 | 12,174 | 06-27-2024 |
$1.9604 | $2.01 | $1.9604 | $2.04 | $1.9201 | 5,818 | 06-26-2024 |
$2.06 | $2.14 | $2.06 | $2.24 | $1.992 | 7,088 | 06-25-2024 |
$2.05 | $2.1 | $2.05 | $2.1048 | $2.05 | 1,941 | 06-24-2024 |
$2.1 | $2.13 | $2.1 | $2.2 | $2.08 | 4,631 | 06-21-2024 |
$2.085 | $2.19 | $2.085 | $2.2163 | $1.9 | 1,958 | 06-20-2024 |
$2.2999 | $2.14 | $2.2999 | $2.2999 | $1.99 | 7,372 | 06-19-2024 |
$2.2999 | $2.14 | $2.2999 | $2.2999 | $1.99 | 7,372 | 06-18-2024 |
$2.08 | $2 | $2.08 | $2.15 | $1.96 | 15,650 | 06-17-2024 |
$2.08 | $2.01 | $2.08 | $2.1 | $1.95 | 3,362 | 06-14-2024 |
$2.1 | $1.9501 | $2.1 | $2.1998 | $1.9501 | 3,688 | 06-13-2024 |
$2.115 | $2.05 | $2.115 | $2.36 | $1.91 | 15,424 | 06-12-2024 |
$2.15 | $2.22 | $2.15 | $2.38 | $2.03 | 7,493 | 06-11-2024 |
$2.1899 | $2.47 | $2.1899 | $2.5153 | $2.14 | 20,037 | 06-10-2024 |
$2.39 | $2.45 | $2.39 | $2.61 | $2.2901 | 9,805 | 06-07-2024 |
$2.39 | $2.44 | $2.39 | $2.45 | $2.38 | 1,790 | 06-06-2024 |
$2.4521 | $2.53 | $2.4521 | $2.6 | $2.35 | 9,697 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
XORTX Therapeutics Inc. Company Name:
XRTX Stock Symbol:
NASDAQ Market:
XORTX Therapeutics Inc. Website:
CALGARY, June 04, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to anno...
CALGARY, Alberta, May 17, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive ...